Biomea Fusion, Inc.(BMEA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BMEA Biomea Fusion, Inc.

盘后交易 04-30 19:22:36 EDT

1.36

-0.09

-6.21%

盘后1.35

-0.01-0.74%

18:55 EDT

最高1.50	最低1.35	成交量201.46万
今开1.47	昨收1.45	日振幅10.34%
总市值9,833万	流通市值9,172万	总股本7,230万
成交额286.73万	换手率2.99%	流通股本6,744万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BMEA","market":"US","secType":"STK","nameCN":"Biomea Fusion, Inc.","latestPrice":1.36,"timestamp":1777579200000,"preClose":1.45,"halted":0,"volume":2014611,"hourTrading":{"tag":"盘后","latestPrice":1.35,"preClose":1.36,"latestTime":"18:55 EDT","volume":14013,"amount":19135.269981,"timestamp":1777589755539,"change":-0.01,"changeRate":-0.007353,"amplitude":0.014706},"delay":0,"changeRate":-0.06206896551724128,"floatShares":67444700,"shares":72299440,"eps":-1.18,"marketStatus":"盘后交易","change":-0.09,"latestTime":"04-30 19:22:36 EDT","open":1.47,"high":1.5,"low":1.35,"amount":2867264.4836628,"amplitude":0.103448,"askPrice":1.48,"askSize":100,"bidPrice":1.35,"bidSize":1864,"shortable":3,"etf":0,"ttmEps":-1.18,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1777593600000},"marketStatusCode":4,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":1.45,"preHourTrading":{"tag":"盘前","latestPrice":1.49,"preClose":1.45,"latestTime":"09:28 EDT","volume":12602,"amount":18859.327769,"timestamp":1777555680077,"change":0.04,"changeRate":0.027586,"amplitude":0.096966},"postHourTrading":{"tag":"盘后","latestPrice":1.35,"preClose":1.36,"latestTime":"18:55 EDT","volume":14013,"amount":19135.269981,"timestamp":1777589755539,"change":-0.01,"changeRate":-0.007353,"amplitude":0.014706},"volumeRatio":1.163373,"impliedVol":0.5427,"impliedVolPercentile":0.2789},"requestUrl":"/m/hq/s/BMEA","defaultTab":"news","newsList":[{"id":"1101358661","title":"Biomea Fusion携手美国四大学术中心 基于数据启动二期临床试验规划","url":"https://stock-news.laohu8.com/highlight/detail?id=1101358661","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101358661?lang=zh_cn&edition=full","pubTime":"2026-04-28 06:03","pubTimestamp":1777327395,"startTime":"0","endTime":"0","summary":"生物制药公司Biomea Fusion, Inc.宣布，将联合美国四所顶尖学术医学中心共同推进其二期临床试验计划。此次合作建立在现有临床试验数据的基础上，标志着该公司在创新疗法开发领域迈出关键一步。\n据悉，该项二期临床试验方案旨在进一步验证实验药物的安全性与有效性。通过与多家权威学术机构的协同合作，Biomea Fusion有望加速临床开发进程，为后续研究奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BMEA","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188895168","title":"Biomea Fusion公司：Icovamenib总体耐受性良好，52周观察期内未发现新的或非预期的安全性信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1188895168","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188895168?lang=zh_cn&edition=full","pubTime":"2026-04-28 06:02","pubTimestamp":1777327333,"startTime":"0","endTime":"0","summary":"Biomea Fusion公司公布的最新临床数据显示，其研究性药物Icovamenib在为期52周的观察期内展现出良好的安全性特征。该药物总体耐受性表现优异，研究过程中未识别出任何新的或非预期的安全性警示信号。\n这项长期观察结果进一步支持了Icovamenib的可耐受性特征，为后续临床开发提供了重要的安全性依据。持续52周的监测数据表明，该药物在延长使用期间保持了稳定的安全性能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4585","BMEA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129778068","title":"Biomea Fusion公布II期Covalent-112试验52周积极数据：Icovamenib治疗12周后1型糖尿病患者C肽水平持续改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1129778068","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129778068?lang=zh_cn&edition=full","pubTime":"2026-04-28 05:38","pubTimestamp":1777325894,"startTime":"0","endTime":"0","summary":"生物制药公司Biomea Fusion近日发布了其针对1型糖尿病研发的II期临床研究Covalent-112的52周积极结果。数据显示，患者在完成12周Icovamenib治疗后，展现出C肽指标的显著提升，且疗效表现出持久性特征。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4585","BMEA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126155446","title":"Biomea Fusion公司：两项II期研究26周主要终点数据预计2026年第四季度公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1126155446","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126155446?lang=zh_cn&edition=full","pubTime":"2026-03-31 19:01","pubTimestamp":1774954918,"startTime":"0","endTime":"0","summary":"Biomea Fusion公司宣布，其两项II期临床研究的26周主要终点顶线数据，预计将于2026年第四季度揭晓。该数据的公布将是评估其在研疗法有效性与安全性的关键里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4585","BMEA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124321384","title":"Biomea Fusion宣布新型II期研究项目完成首例患者给药 纳入标准疗法失效的2型糖尿病患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1124321384","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124321384?lang=zh_cn&edition=full","pubTime":"2026-03-31 19:01","pubTimestamp":1774954880,"startTime":"0","endTime":"0","summary":"Biomea Fusion, Inc.近日宣布，其新启动的II期临床研究项目已完成首例患者给药。该试验旨在招募对现有标准疗法反应不足的2型糖尿病患者，探索创新疗法的安全性与有效性。\n此次研究标志着公司在代谢疾病治疗领域的重要进展。通过聚焦现有治疗方案失效的患者群体，该项目有望为糖尿病治疗开辟新的可能性。\n随着首例患者成功接受给药，后续临床试验将按计划推进。公司将持续关注研究数据，为未来临床开发提供关键依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BMEA","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619160118","title":"Biomea Fusion, Inc.盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619160118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619160118?lang=zh_cn&edition=full","pubTime":"2026-03-12 21:47","pubTimestamp":1773323264,"startTime":"0","endTime":"0","summary":"北京时间2026年03月12日21时47分，Biomea Fusion, Inc.股票出现波动，股价快速下挫5.33%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体跌幅为1.18%。其相关个股中，Codexis, Inc.、Quantum Biopharma Ltd.、Mindwalk Holdings Corp.涨幅较大，Scisparc Ltd.、60 Degrees Pharmaceuticals, Inc.、Lunai Bioworks Inc.较为活跃，换手率分别为513.63%、149.15%、88.18%，振幅较大的相关个股有Codexis, Inc.、Mindwalk Holdings Corp.、Quantum Biopharma Ltd.，振幅分别为33.86%、19.53%、19.47%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床阶段的糖尿病和肥胖症药物公司，专注于发现和开发用于治疗代谢疾病患者的口服共价小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031221474497af8fd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031221474497af8fd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4585","BMEA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614010047","title":"Biomea Fusion, Inc.盘中异动 早盘股价大涨6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614010047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614010047?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:31","pubTimestamp":1772029894,"startTime":"0","endTime":"0","summary":"北京时间2026年02月25日22时31分，Biomea Fusion, Inc.股票出现异动，股价大幅上涨6.11%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床阶段的糖尿病和肥胖症药物公司，专注于发现和开发用于治疗代谢疾病患者的口服共价小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225223134a4c7a6f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225223134a4c7a6f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BMEA","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611135964","title":"Biomea Fusion, Inc.盘中异动 股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611135964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611135964?lang=zh_cn&edition=full","pubTime":"2026-02-12 22:50","pubTimestamp":1770907841,"startTime":"0","endTime":"0","summary":"北京时间2026年02月12日22时50分，Biomea Fusion, Inc.股票出现波动，股价急速下跌5.25%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床阶段的糖尿病和肥胖症药物公司，专注于发现和开发用于治疗代谢疾病患者的口服共价小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212225042a49cf3f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212225042a49cf3f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BMEA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603496620","title":"Biomea Fusion, Inc.盘中异动 早盘股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603496620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603496620?lang=zh_cn&edition=full","pubTime":"2026-01-15 22:36","pubTimestamp":1768487767,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日22时36分，Biomea Fusion, Inc.股票出现波动，股价大幅跳水5.25%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床阶段的糖尿病和肥胖症药物公司，专注于发现和开发用于治疗代谢疾病患者的口服共价小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115223607a4c81c5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115223607a4c81c5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BMEA","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601574332","title":"Biomea Fusion, Inc.盘中异动 股价大涨5.56%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601574332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601574332?lang=zh_cn&edition=full","pubTime":"2026-01-08 00:42","pubTimestamp":1767804175,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日00时42分，Biomea Fusion, Inc.股票出现波动，股价大幅上涨5.56%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为2.08%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床阶段的糖尿病和肥胖症药物公司，专注于发现和开发用于治疗代谢疾病患者的口服共价小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108004256953c2ac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108004256953c2ac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BMEA","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142313679","title":"Biomea Fusion在第23届世界胰岛素抵抗、糖尿病与心血管疾病大会上展示Covalent-111研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1142313679","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142313679?lang=zh_cn&edition=full","pubTime":"2025-12-05 20:07","pubTimestamp":1764936422,"startTime":"0","endTime":"0","summary":"Biomea Fusion在第23届世界胰岛素抵抗、糖尿病与心血管疾病大会上展示Covalent-111研究结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA","BK4539","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139832044","title":"Biomea Fusion宣布在第23届世界胰岛素抵抗、糖尿病与心血管疾病大会上进行Icovamenib的口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1139832044","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139832044?lang=zh_cn&edition=full","pubTime":"2025-12-02 05:11","pubTimestamp":1764623469,"startTime":"0","endTime":"0","summary":"Biomea Fusion宣布在第23届世界胰岛素抵抗、糖尿病与心血管疾病大会上进行Icovamenib的口头报告","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BMEA","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586155152","title":"Biomea Fusion, Inc.盘中异动 下午盘股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586155152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586155152?lang=zh_cn&edition=full","pubTime":"2025-11-27 03:51","pubTimestamp":1764186683,"startTime":"0","endTime":"0","summary":"北京时间2025年11月27日03时51分，Biomea Fusion, Inc.股票出现波动，股价大幅上涨5.34%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床阶段的糖尿病和肥胖症药物公司，专注于发现和开发用于治疗代谢疾病患者的口服共价小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127035124978137cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127035124978137cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4539","BK4139","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518331270","title":"Biomea Fusion, Inc.盘中异动 大幅跳水5.17%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518331270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518331270?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:55","pubTimestamp":1741622139,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时55分，Biomea Fusion, Inc.股票出现波动，股价急速下跌5.17%。截至发稿，该股报2.57美元/股，成交量16.4981万股，换手率0.46%，振幅7.01%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3662.66%、2664.64%、874.12%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Scisparc Ltd.，振幅分别为88.14%、78.32%、49.87%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310235540a26a5a2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310235540a26a5a2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BMEA","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517880499","title":"Biomea Fusion, Inc.盘中异动 大幅拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517880499","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517880499?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:40","pubTimestamp":1741117228,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时40分，Biomea Fusion, Inc.股票出现波动，股价快速上涨5.30%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Rapport Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Protagenic Therapeutics, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为1315.96%、1231.18%、1210.94%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Plus Therapeutics, Inc.，振幅分别为122.48%、68.89%、68.09%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305034028989bf335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305034028989bf335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4585","BMEA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516634955","title":"Biomea Fusion, Inc.盘中异动 股价大跌5.02%报2.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634955?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:43","pubTimestamp":1741013020,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时43分，Biomea Fusion, Inc.股票出现波动，股价大幅下挫5.02%。截至发稿，该股报2.75美元/股，成交量2.8127万股，换手率0.08%，振幅6.57%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224340989a1308&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224340989a1308&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BMEA","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514389288","title":"Biomea Fusion, Inc.盘中异动 早盘股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514389288?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:14","pubTimestamp":1740669250,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时14分，Biomea Fusion, Inc.股票出现波动，股价急速上涨5.28%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。其相关个股中，Alpha Tau Medical Ltd C/Wts 、Editas Medicine, Inc.、Quoin Pharmaceuticals Ltd涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为749.56%、111.60%、102.56%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Quoin Pharmaceuticals Ltd，振幅分别为78.88%、43.51%、34.80%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272314109632bab8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272314109632bab8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4539","BMEA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856391","title":"Biomea Fusion, Inc.盘中异动 早盘股价大涨5.23%报2.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856391?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:30","pubTimestamp":1740580226,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时30分，Biomea Fusion, Inc.股票出现波动，股价大幅上涨5.23%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Immunoprecise Antibodies Ltd.、Pyxis Oncology, Inc.、天境生物涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2600.31%、109.73%、82.16%，振幅较大的相关个股有Ocean Biomedical, Inc.、Day One Biopharmaceuticals, Inc.、Os Therapies Incorporated，振幅分别为6.00%、5.59%、4.82%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262230279893aa70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262230279893aa70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4539","BMEA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514013080","title":"Biomea Fusion, Inc.盘中异动 早盘急速下挫5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514013080?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:13","pubTimestamp":1740496397,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时13分，Biomea Fusion, Inc.股票出现异动，股价快速下跌5.33%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1044.73%、583.93%、538.16%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Gri Bio, Inc.、Silexion Therapeutics Corp，振幅分别为63.01%、56.51%、55.83%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231317abdc88ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231317abdc88ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4539","BMEA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513882720","title":"Biomea Fusion, Inc.盘中异动 快速下挫5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513882720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513882720?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:02","pubTimestamp":1740409373,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时02分，Biomea Fusion, Inc.股票出现波动，股价大幅下挫5.49%。截至发稿，该股报3.27美元/股，成交量8.7011万股，换手率0.24%，振幅6.07%。Biomea Fusion, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Avalo Therapeutics, Inc.涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为156.52%、69.90%、25.47%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Biomea Fusion, Inc.公司简介：Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230253abdb15a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230253abdb15a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4539","BK4139","BMEA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biomeafusion.com","stockEarnings":[{"period":"1week","weight":-0.2162},{"period":"1month","weight":0.0985},{"period":"3month","weight":0.2288},{"period":"6month","weight":0.0662},{"period":"1year","weight":-0.3409},{"period":"ytd","weight":0.1694}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.126},{"period":"3month","weight":0.0253},{"period":"6month","weight":0.0433},{"period":"1year","weight":0.2837},{"period":"ytd","weight":0.0435}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Biomea Fusion, Inc.于2017年8月9日根据特拉华州法律注册成立。该公司是一家临床阶段的糖尿病和肥胖症药物公司，专注于开发口服小分子药物。经过战略调整，其核心项目包括用于糖尿病和肥胖症的menin抑制剂icovamenib，以及用于肥胖症的下一代口服GLP-1受体激动剂BMF-650。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.06322},{"month":2,"riseRate":0.4,"avgChangeRate":0.025302},{"month":3,"riseRate":0.4,"avgChangeRate":0.163799},{"month":4,"riseRate":0,"avgChangeRate":-0.144999},{"month":5,"riseRate":0.6,"avgChangeRate":0.133765},{"month":6,"riseRate":0.4,"avgChangeRate":0.081609},{"month":7,"riseRate":0.4,"avgChangeRate":-0.019311},{"month":8,"riseRate":0.8,"avgChangeRate":0.078281},{"month":9,"riseRate":0.4,"avgChangeRate":-0.012411},{"month":10,"riseRate":0.2,"avgChangeRate":-0.126858},{"month":11,"riseRate":0.4,"avgChangeRate":-0.034764},{"month":12,"riseRate":0.4,"avgChangeRate":-0.114655}],"exchange":"NASDAQ","name":"Biomea Fusion, Inc.","nameEN":"Biomea Fusion, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biomea Fusion, Inc.(BMEA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Biomea Fusion, Inc.(BMEA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Biomea Fusion, Inc.,BMEA,Biomea Fusion, Inc.股票,Biomea Fusion, Inc.股票老虎,Biomea Fusion, Inc.股票老虎国际,Biomea Fusion, Inc.行情,Biomea Fusion, Inc.股票行情,Biomea Fusion, Inc.股价,Biomea Fusion, Inc.股市,Biomea Fusion, Inc.股票价格,Biomea Fusion, Inc.股票交易,Biomea Fusion, Inc.股票购买,Biomea Fusion, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biomea Fusion, Inc.(BMEA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Biomea Fusion, Inc.(BMEA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}